News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
Presentation TCT 2019 Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients? Presenter: Justin Davies September 28, 2019
News Conference News TCT 2019 Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Portico Noninferior to Commercial TAVR Valves in IDE Study Caitlin E. Cox September 27, 2019
Presentation TCT 2019 TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures Presenter: Adam Greenbaum September 27, 2019
Presentation TCT 2019 Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making Presenter: Chiu Wong September 27, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients Yael L. Maxwell September 27, 2019
News Opinion Off Script TCT 2019 Off Script: Want a Glimpse of Healthcare 3.0? Look Beyond Physician Burnout Kwan S. Lee September 27, 2019
Presentation TCT 2019 PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves Presenter: Raj Makkar September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
Presentation TCT 2019 TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc. Presenter: John Forrest September 26, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
Presentation TCT 2019 A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR Presenter: Davide Capodanno September 26, 2019
Presentation TCT 2019 Remaining Data Gaps After the Low-Risk TAVR RCTs Presenter: Michael Borger September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the Evolut Low-Risk Trial Presenter: Michael Reardon September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the PARTNER 3 Trial Presenter: Martin Leon September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019